CLO26-102: Progression-Free Survival of Pembrolizumab Monotherapy Versus Combination Therapy With Chemotherapy as First-Line Treatment in Advanced or Metastatic Non-Small-Cell Lung Cancer Without EGFR/ALK Mutations
用户EO9nReo4Hj6s
1个月前
81
10
已关闭
文献链接: https://jnccn.org/view/journals/jnccn/24/3.5/article-CLO26-102.xml
其他信息:
出版社: Harborside Press, LLC
作者: Woojung Yang; Youjin Oh

